BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37399803)

  • 1. Gene Expression and Early Radiation Response of Two Distinct Neuroblastoma Cell Lines.
    Ritner C; Popović J; Abouzeid A; Li Y; Paunesku T; Papineni R; Woloschak G
    Oncology; 2023; 101(7):446-456. PubMed ID: 37399803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.
    Tivnan A; Tracey L; Buckley PG; Alcock LC; Davidoff AM; Stallings RL
    BMC Cancer; 2011 Jan; 11():33. PubMed ID: 21266077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment.
    Roth SA; Knutsen E; Fiskaa T; Utnes P; Bhavsar S; Hald ØH; Løkke C; Mestdagh P; Johansen SD; Flægstad T; Einvik C
    Cancer Lett; 2016 Mar; 372(1):128-36. PubMed ID: 26708804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
    Cole KA; Attiyeh EF; Mosse YP; Laquaglia MJ; Diskin SJ; Brodeur GM; Maris JM
    Mol Cancer Res; 2008 May; 6(5):735-42. PubMed ID: 18505919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo.
    Chakrabarti M; Banik NL; Ray SK
    Exp Cell Res; 2013 Jun; 319(10):1575-85. PubMed ID: 23562653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis.
    Cheung IY; Farazi TA; Ostrovnaya I; Xu H; Tran H; Mihailovic A; Tuschl T; Cheung NK
    Genes Chromosomes Cancer; 2014 Oct; 53(10):803-14. PubMed ID: 24898736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of miR-7-1 increases efficacy of green tea polyphenols for induction of apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-DZ cells.
    Chakrabarti M; Ai W; Banik NL; Ray SK
    Neurochem Res; 2013 Feb; 38(2):420-32. PubMed ID: 23192662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
    Welch C; Chen Y; Stallings RL
    Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR‑410 in human neuroblastoma cells.
    Boyineni J; Tanpure S; Gnanamony M; Antony R; Fernández KS; Lin J; Pinson D; Gondi CS
    Int J Oncol; 2016 Oct; 49(4):1394-406. PubMed ID: 27498840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity.
    Samaraweera L; Grandinetti KB; Huang R; Spengler BA; Ross RA
    BMC Cancer; 2014 May; 14():309. PubMed ID: 24885481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1.
    Creevey L; Ryan J; Harvey H; Bray IM; Meehan M; Khan AR; Stallings RL
    Mol Cancer; 2013 Mar; 12():23. PubMed ID: 23531080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-34a inhibits proliferation, migration and invasion of paediatric neuroblastoma cells via targeting HNF4α.
    Li Z; Chen H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3072-3078. PubMed ID: 31343368
    [No Abstract]   [Full Text] [Related]  

  • 13. miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase.
    Qu H; Zheng L; Pu J; Mei H; Xiang X; Zhao X; Li D; Li S; Mao L; Huang K; Tong Q
    Hum Mol Genet; 2015 May; 24(9):2539-51. PubMed ID: 25616966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early targets of miR-34a in neuroblastoma.
    De Antonellis P; Carotenuto M; Vandenbussche J; De Vita G; Ferrucci V; Medaglia C; Boffa I; Galiero A; Di Somma S; Magliulo D; Aiese N; Alonzi A; Spano D; Liguori L; Chiarolla C; Verrico A; Schulte JH; Mestdagh P; Vandesompele J; Gevaert K; Zollo M
    Mol Cell Proteomics; 2014 Aug; 13(8):2114-31. PubMed ID: 24912852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by the neural apoptosis inhibitory protein and miR-520f.
    Harvey H; Piskareva O; Creevey L; Alcock LC; Buckley PG; O'Sullivan MJ; Segura MF; Gallego S; Stallings RL; Bray IM
    Int J Cancer; 2015 Apr; 136(7):1579-88. PubMed ID: 25137037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.
    Buechner J; Tømte E; Haug BH; Henriksen JR; Løkke C; Flægstad T; Einvik C
    Br J Cancer; 2011 Jul; 105(2):296-303. PubMed ID: 21654684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.
    Foley NH; Bray IM; Tivnan A; Bryan K; Murphy DM; Buckley PG; Ryan J; O'Meara A; O'Sullivan M; Stallings RL
    Mol Cancer; 2010 Apr; 9():83. PubMed ID: 20409325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells.
    Khan FH; Pandian V; Ramraj S; Aravindan S; Herman TS; Aravindan N
    BMC Genomics; 2015 Jul; 16(1):501. PubMed ID: 26148557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-192 directly binds and regulates Dicer1 expression in neuroblastoma.
    Feinberg-Gorenshtein G; Guedj A; Shichrur K; Jeison M; Luria D; Kodman Y; Ash S; Feinmesser M; Edry L; Shomron N; Weizman A; Yaniv I; Avigad S
    PLoS One; 2013; 8(11):e78713. PubMed ID: 24223844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
    Liu HJ; Li GL; Lei PC
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.